ProQR Therapeutics BV (PRQR) — Working Capital to Net Assets Ratio
ProQR Therapeutics BV (PRQR) has a Working Capital to Net Assets ratio of 109.2% as of June 2026. Working capital of $86.72 Million (current assets of $121.58 Million minus current liabilities of $34.86 Million) is measured against net assets of $79.44 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See ProQR Therapeutics BV defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ProQR Therapeutics BV Working Capital to Net Assets (2012–2025)
This chart shows how ProQR Therapeutics BV's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 109.2%, reflecting working capital of $86.72 Million against net assets of $79.44 Million USD. For the complete balance sheet picture, see balance sheet size of ProQR Therapeutics BV.
Annual Working Capital to Net Assets for ProQR Therapeutics BV (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for ProQR Therapeutics BV from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check PRQR asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 137.1% | $79.49 Million | $57.99 Million | $117.59 Million | $38.10 Million | ▲ +7.3 pp |
| 2024 | 129.8% | $119.02 Million | $91.70 Million | $159.31 Million | $40.28 Million | ▼ -79.9 pp |
| 2023 | 209.7% | $95.86 Million | $45.72 Million | $133.65 Million | $37.78 Million | ▲ +9.5 pp |
| 2022 | 200.2% | $142.45 Million | $71.17 Million | $164.85 Million | $22.40 Million | ▲ +55.4 pp |
| 2021 | 144.7% | $186.37 Million | $128.76 Million | $217.75 Million | $31.38 Million | ▲ +21.4 pp |
| 2020 | 123.3% | $85.31 Million | $69.19 Million | $97.91 Million | $12.60 Million | ▲ +12.8 pp |
| 2019 | 110.5% | $116.37 Million | $105.33 Million | $128.71 Million | $12.34 Million | ▲ +2.4 pp |
| 2018 | 108.1% | $100.21 Million | $92.69 Million | $108.37 Million | $8.16 Million | ▲ +1.1 pp |
| 2017 | 107.0% | $50.51 Million | $47.22 Million | $60.71 Million | $10.20 Million | ▲ +2.9 pp |
| 2016 | 104.1% | $58.33 Million | $56.05 Million | $65.41 Million | $7.08 Million | ▲ +1.3 pp |
| 2015 | 102.8% | $100.25 Million | $97.55 Million | $106.21 Million | $5.96 Million | ▲ +1.4 pp |
| 2014 | 101.4% | $134.17 Million | $132.38 Million | $137.82 Million | $3.65 Million | ▲ +841.8 pp |
| 2013 | -740.4% | $908.07K | $-122.64K | $5.87 Million | $4.96 Million | ▼ -898.0 pp |
| 2012 | 157.6% | $205.67K | $130.52K | $394.20K | $188.53K | — |